EURACTIV have reported on Copenhagen Economics’ recent work for the European Expert Group for Orphan Drug Incentives.
The report contains 14 proposals on how to address the unmet needs of rare disease patients and looks at how to improve the OMP incentive framework while reflecting the different perspectives of the various stakeholders.
Read the full article here: EURACTIV
Read the full “Orphan Medicine Incentives” Report HERE.
Click on this LINK for a video summarising the work of the Expert Group tasked with examining how to improve the situation for patients in Europe afflicted with rare diseases: